Structure Therapeutics
This role oversees small molecule CMC projects for analytical methodology development and characterization of drug substances and products. The position manages interactions with CROs and CDMOs to ensure high-quality results and regulatory compliance while preparing documentation for regulatory filings.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
Structure Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Senior Manager or Associate Director, Analytical Development
GSK plc
Senior Scientist, Analytical Development
Neurocrine Biosciences
Senior Director of Analytical Development
Centessa Pharmaceuticals
Scientist, CMC Analytical
City Therapeutics
Director, Analytical Development
Crinetics Pharmaceuticals
Director, CMC – Small Molecule Chemistry
Pathos